We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-13.79%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$5.71B
AUM Growth
-$882M
Cap. Flow
+$87.1M
Cap. Flow %
1.53%
Top 10 Hldgs %
29.56%
Holding
945
New
191
Increased
229
Reduced
128
Closed
35

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$87M
2
NKE icon
Nike
NKE
+$76.2M
3
TSM icon
TSMC
TSM
+$49.6M
4
UAL icon
United Airlines
UAL
+$32M
5
AWK icon
American Water Works
AWK
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 21.35%
2 Financials 17.15%
3 Communication Services 12.3%
4 Consumer Discretionary 11.48%
5 Technology 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPD icon
376
Expeditors International
EXPD
$22.3B
$285K 0.01%
4,185
HES
377
DELISTED
Hess
HES
$284K 0.01%
7,000
-1,138
-14% -$64.9K
LBTYK icon
378
Liberty Global Class C
LBTYK
$3.63B
$284K 0.01%
13,744
AGG icon
379
iShares Core US Aggregate Bond ETF
AGG
$137B
$283K 0.01%
2,664
-169
-6% -$17.7K
CDK
380
DELISTED
CDK Global, Inc.
CDK
$282K ﹤0.01%
5,879
+2,225
+61% +$117K
RSG icon
381
Republic Services
RSG
$64.5B
$276K ﹤0.01%
+3,830
New +$280K
RTN
382
DELISTED
Raytheon Company
RTN
$271K ﹤0.01%
1,767
-1,660
-48% -$297K
PNC icon
383
PNC Financial Services
PNC
$100B
$266K ﹤0.01%
2,277
+1,025
+82% +$131K
NBIX icon
384
Neurocrine Biosciences
NBIX
$16.7B
$262K ﹤0.01%
3,675
ELAN icon
385
Elanco Animal Health
ELAN
$12.8B
$247K ﹤0.01%
7,847
OKE icon
386
Oneok
OKE
$55.6B
$245K ﹤0.01%
4,548
+3,269
+256% +$203K
GLMD icon
387
Galmed Pharmaceuticals
GLMD
$4.83M
$242K ﹤0.01%
+197
New +$344K
SHY icon
388
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
$238K ﹤0.01%
2,844
LRCX icon
389
Lam Research
LRCX
$369B
$235K ﹤0.01%
17,240
-1,940
-10% -$27.8K
TFCFA
390
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$222K ﹤0.01%
4,604
TRV icon
391
Travelers Companies
TRV
$78B
$220K ﹤0.01%
1,832
-95
-5% -$11.9K
TROW icon
392
T. Rowe Price
TROW
$24.3B
$218K ﹤0.01%
2,366
PTCT icon
393
PTC Therapeutics
PTCT
$5.68B
$216K ﹤0.01%
6,307
AXS icon
394
AXIS Capital
AXS
$7.72B
$214K ﹤0.01%
4,150
GM icon
395
General Motors
GM
$79.3B
$211K ﹤0.01%
6,306
+5,068
+409% +$175K
QVCGA
396
DELISTED
QVC Group Inc Series A
QVCGA
$211K ﹤0.01%
223
CAT icon
397
Caterpillar
CAT
$382B
$210K ﹤0.01%
1,650
+580
+54% +$75.5K
VGK icon
398
Vanguard FTSE Europe ETF
VGK
$30.8B
$208K ﹤0.01%
4,273
+5
+0.1% +$258
MSGS icon
399
Madison Square Garden
MSGS
$9.27B
$207K ﹤0.01%
1,087
SABR icon
400
Sabre
SABR
$779M
$204K ﹤0.01%
9,429
+1,350
+17% +$32.7K

Similar funds

Rockefeller Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Rockefeller Capital Management held 945 positions worth $5.71B, down 13% from $6.59B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rockefeller Capital Management's Q4 2018 filing shows 191 new, 229 increased, 128 reduced and 35 closed positions. Its largest new stake was iShares US Regional Banks ETF: 503,053 shares worth $20M. The largest sale was Shire pic, an estimated $87M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.

  • Rockefeller Capital Management's largest Q4 2018 buy was iShares US Regional Banks ETF: 503,053 shares worth $20M.
  • Rockefeller Capital Management added most to Amazon in Q4 2018, an estimated $39.9M increase.
  • Rockefeller Capital Management's biggest Q4 2018 reduction was Shire pic, cutting an estimated $87M.
  • Rockefeller Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $1.9M.
  • Rockefeller Capital Management's ten largest holdings make up 30% of its $5.71B portfolio in Q4 2018.
  • Rockefeller Capital Management opened 191 new positions and closed 35 in Q4 2018.
  • Rockefeller Capital Management's portfolio value fell 13% quarter-over-quarter to $5.71B.

Based on Rockefeller Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.